Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fieldable Ultrasound Treatment to Enhance Inflammatory-Proliferative Phase Transition and Reduce Wound Healing Time

NCT05796492 is registered in ClinicalTrials.gov with General Electric Research as lead sponsor.

NCT NCT05796492
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05796492 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fieldable Ultrasound Treatment to Enhance Inflammatory-Proliferative Phase Transition and Reduce Wound Healing Time
Lead sponsor
General Electric Research
Phase
Not applicable
Overall status
Terminated
Start date
June 22, 2023
Completion date
December 19, 2024
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

2nd degree burn of the skin, burn wound